Home > Boards > US Listed > Biotechs >

Mediwound Ltd (MDWD)

MDWD RSS Feed 		Add MDWD Price Alert      Hide Sticky   Hide Intro
Moderator: midastouch017
Search This Board: 
Last Post: 5/17/2022 1:55:55 PM - Followers: 2 - Board type: Free - Posts Today: 0

Description

MediWound Ltd., an integrated biopharmaceutical company, focuses on developing, manufacturing, and commercializing novel therapeutics products to address unmet needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; and MWPC003 for connective tissue disorders. MediWound Ltd. was founded in 2000 and is headquartered in Yavne, Israel.

MediWound Ltd.

42 Hayarkon Street
Yavne 8122745
Israel
972 7 797 14100
http://www.mediwound.com

MDWD
Current Price
Volume:
Bid Ask Day's Range
MDWD Detailed Quote
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
MDWD News: Wells Fargo Thinks Mediwound’s Stock is Going to Recover 05/18/2022 04:42:45 AM
MDWD News: Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) 05/17/2022 03:07:10 AM
MDWD News: Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) 05/17/2022 03:05:51 AM
MDWD News: Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) 05/12/2022 03:05:11 AM
MDWD News: Mediwound (MDWD) Gets a Buy Rating from H.C. Wainwright 03/18/2022 02:17:00 AM
PostSubject
#130  Sticky Note MediWound Announces Peer-Reviewed Paper Detailing EscharEx Phase 2 midastouch017 07/09/21 08:17:14 AM
#191   MediWound Ltd. (MDWD) CEO Sharon Malka on Q1 midastouch017 05/17/22 01:55:55 PM
#190   MediWound Announces CEO Transition midastouch017 05/17/22 08:07:58 AM
#189   MediWound Reports First Quarter 2022 Financial Results midastouch017 05/17/22 08:05:57 AM
#188   MediWound Q1 2022 Earnings Preview midastouch017 05/16/22 12:55:33 PM
#187   MediWound Announces Positive Results from Its U.S. Phase midastouch017 05/12/22 08:45:44 AM
#186   MediWound to Report First Quarter Financial Results and midastouch017 05/11/22 05:48:04 AM
#185   MediWound's EscharEx Highlighted in Poster and Oral Presentation midastouch017 04/12/22 08:12:18 AM
#184   MediWound to Present EscharEx Clinical Data at the midastouch017 03/29/22 08:21:12 AM
#183   MediWound Announces Exercise of Over-Allotment Option midastouch017 03/23/22 01:44:10 AM
#182   MediWound Announces Exercise of Over-Allotment Option midastouch017 03/23/22 01:44:09 AM
#181   MediWound Announces Last Patient Out in EscharEx U.S. midastouch017 03/21/22 09:19:48 AM
#180   Mediwound (MDWD) Gets a Buy Rating from H.C. Wainwright midastouch017 03/18/22 12:06:06 PM
#179   MediWound Ltd. (MDWD) CEO Sharon Malka on Q4 midastouch017 03/17/22 01:04:23 PM
#178   MediWound GAAP EPS of -$0.15 in-line, revenue of midastouch017 03/17/22 08:57:07 AM
#177   MediWound Reports Fourth Quarter and Full Year 2021 midastouch017 03/17/22 08:53:04 AM
#176   MediWound Q4 2021 Earnings Preview midastouch017 03/16/22 11:02:07 AM
#175   MediWound Announces Closing of Public Offering of Ordinary Shares midastouch017 03/11/22 12:47:22 AM
#174   MediWound to Report Fourth Quarter and Year End midastouch017 03/10/22 08:23:57 AM
#173   MediWound (MDWD) Could Find Support Soon, Here's Why midastouch017 03/09/22 12:23:41 PM
#172   MediWound Ltd. (NASDAQ: MDWD) Now Carries A 12-Month midastouch017 03/05/22 07:58:12 AM
#171   MediWound Announces Pricing of Public Offering of Ordinary Shares midastouch017 03/03/22 09:33:55 AM
#170   MediWound slides on proposed stock offering midastouch017 03/03/22 01:00:04 AM
#169   MediWound to Present at Upcoming Investor Conferences in March midastouch017 03/01/22 08:15:17 AM
#168   Earnings Preview: MediWound (MDWD) Q4 Earnings Expected to Decline midastouch017 02/18/22 12:28:58 PM
#167   MediWound Awarded a U.S. Department of Defense Research midastouch017 02/17/22 08:19:06 AM
#166   MediWound to Present at Upcoming Investor Conferences in February midastouch017 02/14/22 10:19:12 AM
#165   MediWound wins $9M additional BARDA funding for NexoBrid midastouch017 02/10/22 08:24:15 AM
#164   MediWound Announces Additional $9 Million in Funding from midastouch017 02/10/22 08:17:45 AM
#163   Wells Fargo analyst Jacob Hughes reiterated an Overweight midastouch017 01/28/22 08:21:30 AM
#162   MediWound Ltd (MDWD) Reports Positive Ph2 EscharEx Data midastouch017 01/26/22 01:26:44 AM
#161   MediWound reports positive results from Phase 2 trial midastouch017 01/24/22 08:06:43 AM
#160   2.9087+0.2587 (+9.7623%) midastouch017 01/05/22 11:19:42 AM
#159   MediWound reports positive initial data from Phase 2 midastouch017 12/20/21 07:51:12 AM
#158   MediWound Announces Positive Initial Data from its U.S. midastouch017 12/20/21 07:34:50 AM
#157   MediWound Completes Enrollment of its EscharEx U.S. Phase midastouch017 12/06/21 08:20:31 AM
#156   EMA Provides Regulatory Path for Pediatric Label Extension midastouch017 11/18/21 08:32:16 AM
#155   MediWound Ltd. (MDWD) CEO Sharon Malka on Q3 midastouch017 11/16/21 12:48:25 PM
#154   MediWound Reports Third Quarter 2021 Financial Results midastouch017 11/16/21 07:48:03 AM
#153   MediWound to Report Third Quarter 2021 Financial Results midastouch017 11/04/21 09:11:05 AM
#152   3.9400 +0.57 (+16.91%) midastouch017 10/19/21 06:15:08 AM
#151   MediWound Announces Peer-Reviewed Publication of EscharEx In-Vivo Head-to-Hea midastouch017 10/04/21 08:18:26 AM
#150   Warning: MDWD has been downgraded to Very Bearish. midastouch017 09/17/21 12:31:23 AM
#149   MediWound to Present at Upcoming Investor Conferences midastouch017 09/04/21 01:32:24 AM
#148   Nice would be connection of midastouch017 08/31/21 01:14:47 AM
#147   VCEL raising $200 million, for corporate purposes realfast95 08/30/21 06:35:02 PM
#146   Methinks MDWD sp will get a significant price midastouch017 08/30/21 01:10:17 PM
#145   Mediwound Ltd (MDWD) CEO Sharon Malka on Q2 midastouch017 08/10/21 11:55:51 PM
#144   MediWound EPS misses by $0.01, beats on revenue midastouch017 08/10/21 07:57:46 AM
#143   MediWound Reports Second Quarter Financial Results midastouch017 08/10/21 07:56:47 AM
#142   MediWound to Report Second Quarter 2021 Financial Results midastouch017 08/03/21 12:51:43 AM
PostSubject
© 2022 InvestorsHub.com, Inc.
Consent Preferences